nintedanibPulmonary fibrosisoxygen therapy
…Pulmonary fibrosis is a progressive disease, often treated with nintedanib. However, its use is frequently associated with adverse effects…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 181–240 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Clarithromycin17Antibiotic17Anticoagulants17fludarabine17Inclisiran16Atropine16Secukinumab16Caffeine16Salbutamol16Ondansetron16Dapagliflozin16Naloxone16Methylene blue16Anakinra16Fluconazole16Rilpivirine16Analgesics16Rocuronium16Proton pump inhibitor16Osimertinib15Atogepant15ELAFIBRANOR15Pirfenidone15Dabigatran15Obinutuzumab15Rosuvastatin15Medicines15Amphotericin B15Ketorolac15Carbon Monoxide15ACE inhibitors15Phenylephrine15Glucocorticoid15non-steroidal anti-inflammatory drugs15Empagliflozin14Rimegepant14Fremanezumab14FeNO14Olaparib14GA14Relatlimab14IL-1214Lactulose14SpironolacTone14Mannitol14Levothyroxine14bleomycin14Sodium-glucose cotransporter 2 inhibitors14Beta Blockers14Axicabtagene Ciloleucel14adrenaline14Broad-spectrum antibiotics14Etoposide14Tenofovir14Intravenous Immunoglobulin14UPA13LMWH13Liposomal bupivacaine13Baricitinib13Ruxolitinib13
Articles mentioning drugs
10,506 articles · page 346 of 876atezolizumabES-SCLCtertiary hospitalextensive-stage small-cell lung cancersolid tumoursanticancer immunotherapy
…er (ES-SCLC).Aim and Objectives To assess whether the timing of atezolizumab infusions (early vs late) is associated with efficacy in ES-SCL…
omalizumabtezepelumabdupilumabmepolizumabsevere paediatric asthmaSevere AsthmaBiologic therapiesPSAUbiologic therapyatopic dermatitis
… 41.9% allergy and atopic dermatitis. Biologics prescribed were omalizumab (61.4%), dupilumab (22.7%), mepolizumab (11.4%), and tezepeluma…
eptinezumabnational health systemCMMMDbotulinum toxinHFEMchronic migraine
…(≥15 MMD) or HFEM (10-15 MMD) who received at least one dose of eptinezumab at our hospital between April 24 and June 25.The following data…
PrEPChlamydia trachomatisNeisseria gonorrhoeaetertiary hospitalHIV
…urealyticum, and Chlamydia trachomatis Conclusion and Relevance PrEP was highly effective and well tolerated. The high incidence of …
MicromedexAIsoncologyOncoAssistUpToDateDrugBank
…veness; OncoAssist reported 123 and 33, UpToDate 41 and 31, and Micromedex 20 and 8, respectively. The Fleiss’ kappa coefficient for DDI d…
meropenemβ-lactamsAcinetobacter spptertiary hospital
…O type (75% vs 93,3% veno-venous), or sampling time relative to meropenem initiation and circuit change. Clinical factors (obesity, mecha…
Tocilizumabcorticosteroidshaematologic malignanciesuniversity hospitalCRSCAR-T cell therapycytokine release syndromemultiorgan failure
…was uncommon in both groups (10% in trials vs 1% in real life). Tocilizumab was administered in all trial cases (20/20) versus 66% (200/303…
ferric carboxymaltoseiron deficiencytertiary care hospitalPharmaceutical interventionPharmacy and Therapeutics Committee
…ound and Importance There is a need to evaluate the adequacy of ferric carboxymaltose prescriptions in relation to the actual analytical requirements…
TecovirimatmonkeypoxWHOMPOXOrthopoxvirustertiary hospital
…respectively. Only one had previously received the MPOX vaccine.Tecovirimat was prescribed in severe cases: Among HIV+ patients, 3 had ocul…
Ruxolitinibacute lymphoblastic leukaemiaacute myeloid leukaemiaGvHDGraft-versus-host diseaseCommittee for Rational Use of Medicines and Medical DevicesaGvHD
…allogeneic haematopoietic stem cell transplantation(allo-HSCT). Ruxolitinib is effective in refractory cases, but real-world safety data ar…
tezepelumabsevere asthmatertiary hospitalmaintenance therapy
…erences (p>0.05).Conclusion and Relevance Patients treated with tezepelumab showed improvements in lung function in both groups, although t…